Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Track record
Movers
The Lead Compound
Home
›
Targets
› COL7A1
COL7A1
(1 companies · 1 programs)
Companies with an active program directed at COL7A1.
Eloxx Pharmaceuticals, Inc.
ELOX
ZKN-013
— Recessive Dystrophic Epidermolysis Bullosa
Phase 1